TL1A amplifies Th1/Th17 immune responses through DR3 and participates in intestinal mucosal inflammation, synovial injury, psoriatic lesions, and intestinal wall fibrosis. It has become an important target for autoimmune disease mechanism research and antibody drug development.
危险品化学品经营许可证（带存储）